Additional file 1: Table S1. of Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study
Hisashi Yamanaka
Yoshiya Tanaka
Tsutomu Takeuchi
Naonobu Sugiyama
Hirotoshi Yuasa
Shigeyuki Toyoizumi
Yosuke Morishima
Tomohiro Hirose
Samuel Zwillich
10.6084/m9.figshare.c.3615428_D1.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Tofacitinib_an_oral_Janus_kinase_inhibitor_as_monotherapy_or_with_background_methotrexate_in_Japanese_patients_with_rheumatoid_arthritis_an_open-label_long-term_extension_study/4376375
Summary of seven patient deaths. (PDF 14 kb)
2016-01-28 05:00:00
Tofacitinib
Japanese
Rheumatoid arthritis
Long-term extension